AOA cautions consumers about claims from online eye exams

Article

To protect consumers’ eye and vision health, the American Optometric Association is warning the public about the false claims that they provide an online “eye exam,” stating that these claims are confusing and misleading.

St. Louis, MO-To protect consumers’ eye and vision health, the American Optometric Association is warning the public about the false claims that they provide an online “eye exam," stating that these claims are confusing and misleading. 

“To help safeguard consumers, the AOA is closely monitoring Internet-linked assertions about eye exams without doctors,” says Mitchell T. Munson, OD, president of the AOA. “And, we’ll play an even more active role in fact-checking false claims.”

According to the AOA, consumers should understand that only an in-person exam by an optometrist or an ophthalmologist can determine how well they see and whether or not they need corrective lenses. In addition, every day, in patients seen for routine examinations optometrists diagnose and manage diabetes, hypertension, glaucoma, macular degeneration, or cataracts.

According to the AOA, a person or company claiming to perform an eye exam without physically examining a patient is offering insufficient, ambiguous information and is contributing to a patient believing-incorrectly-that his eye health needs have been met. The organization also says the claims of those who market online eye testing should be thoroughly scrutinized and evaluated; these claims may harm patients and hinder care needed to diagnose important underlying, and often asymptomatic, health problems. Any delay in intervention will result in progressive damage to vision, and more costly and intensive treatments later in life. 

Recent Videos
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
Ali Tafreshi sits down with Optometry Times to discuss Topcon's "Healthcare from the Eye" initiative.
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
OptiLIFT in action: Dr. Julie McLaughlin's experience with the new device
© 2025 MJH Life Sciences

All rights reserved.